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Claudins are tetraspan transmembrane proteins of tight junctions. They determine the barrier properties of this type of cell–cell contact existing
between the plasma membranes of two neighbouring cells, such as occurring in endothelia or epithelia. Claudins can completely tighten the
paracellular cleft for solutes, and they can form paracellular ion pores. It is assumed that the extracellular loops specify these claudin functions. It
is hypothesised that the larger first extracellular loop is critical for determining the paracellular tightness and the selective ion permeability. The
shorter second extracellular loop may cause narrowing of the paracellular cleft and have a holding function between the opposing cell membranes.
Sequence analysis of claudins has led to differentiation into two groups, designated as classic claudins (1–10, 14, 15, 17, 19) and non-classic
claudins (11–13, 16, 18, 20–24), according to their degree of sequence similarity. This is also reflected in the derived sequence-structure function
relationships for extracellular loops 1 and 2. The concepts evolved from these findings and first tentative molecular models for homophilic
interactions may explain the different functional contribution of the two extracellular loops at tight junctions.
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Tight junctions (TJ) are the most apical type of cell–cell
contact in the lateral membrane between polarised cells, such as
those existing in endothelia and epithelia. TJ show a wide
variability of tightness in different organs, ranging from almost
Table 1
Distribution, function and pathology of claudins with particular consideration of paracellular and extracellular aspects
Claudin Tissue expression Paracellular function Pathologies Other observations
1 – Typical for tight epithelia, e.g. epidermis [41],
distal nephron [97], gallbladder [98]
– Mammalian epidermal barrier [41] – Hepatitis C virus co-receptor in ECL1 [95] – KO demonstrate tightening of epidermis for water [41]
– Mouse prostate [99] – Overexpression: melanoma cells, activated by PKC leads to
MMP-2 overexpression and cell motility [103]; colorectal ca. [104]
– MAPK [32], PKC [33], WNK4 [37] phosphorylate
C-terminal tail
– Human ovarian epithelium [100] – Mutations: ichthyosis, sclerosing cholangitis [105]
– Inner ear [57] – Downregulation: squamous cell ca. [106], glioblastoma [101],
prostate adeno ca. [107]
– Brain capillary endothelium [101] a
– Mouse choroid plexus epithelium TJ [102] a
2 – Typical for leaky epithelia, e.g. intestinal crypts [108],
proximal renal tubule [80,97], choroid plexus [102]
– Increases paracellular cation permeability
in MDCK-C7: Na+=K+Ncholine+≫Cl− [9]
– Upregulation in Crohn's disease [94] – WNK4 phosphorylates C-terminal tail [37]
– Human ovarian surface epithelium [100]
– Inner ear [57]
3 – Mouse prostate [99] – Constitutes TJ strands in endothelium [81] – Overexpression in ca.: ovarian [100], prostate [107],
human colorectal [109], breast [110]
– PKA [34], WNK4 [37] phosphorylate C-terminal tail
– Human gallbladder [98] – Receptor for CPE [111], binds the ECL2 [96]
– Inner ear [57], brain capillary endothelium [81] – Loss from BBB TJ in glioblastoma and, encephalomyelitis [81]
– Tighter segments of nephron [80]
– Liver/intestinal epithelial cells [108]
4 – Mouse prostate [99] – Reduces paracellular cation permeability
in MDCK-II [53]
– Overexpression: ovarian adeno ca. [44,100], human colorectal
adeno ca. [109]; prostate ca. [107], human breast ca. [110]
– WNK4 phosphorylates C-terminal tail
[37]; EphA2 [38]
– Human gallbladder [98] – Claudin-4 knock down in bladder
tumour cells reduces TER [45]
– Receptor for CPE [111] – ECL1: basic→acid aa exchange elevates
paracellular Na+ permeability [66]
5 – Typical for endothelia, e.g. brain capillary
endothelial cells [42,75]
– Reduces paracellular cation
permeability in MDCK-II [8]
– Downregulation: Crohn's disease [94], DiGeorge/Velo cardio-
facial syndrome [112], hyperplastic vessels in glioblastoma [101]
– KO: small molecules cross BBB [42]
– Mouse prostate [99] – Constitutes TJ strands in endothelial
cells [75]
– Upregulation: pancreatic ca. [113] – PKA phosphorylates C-terminal tail [35]
– Human ovarian surface epithelium [100] – ECL2: narrowing paracellular cleft,
holding of opposing cell/claudin [16]
– ECL1: Cys→Ala reduces tightness [8]
– Human colon epithelium [46] – ECL2: oligomerisation [15], contributes to
paracellular enrichment [16]
– PKCα/ζ phosphorylation: disappearence
from membrane, ζ reduces TER [36]
6 – Embryonic epithelia [56] – May play role in maturational changes
in paracellular permeability [59]
– Transgenic mice: skin barrier defect
(abnormal epidermal differentiation markers) [114]
– High expression: neonatal proximal tubule,
thick ascending limb, distal convoluted tubule,
collecting duct (but not adult kidney) [59]
7 – Mouse prostate [99] – Increases paracellular Na+-, decreases
Cl−-permeability in LLC [51]
– Downregulation: breast- [117], head-, neck ca. [118] – Replacement of negatively charged aa by positive ones
in ECL1 but not ECL2 increase Cl−-permeability [12]
– Duodenum, jejunum, ileum, colon [58] – Paracellular Cl−-barrier, Na+-pore [51] – Elevated: stomach ca. [119] – Knock down in LLC decreases paracellular
Cl−-permeability [54]
– Human palatine tonsillar epithelium [115]
– Nephron segments primarily at the
basolateral membrane [116]
8 – Mouse prostate [99], inner ear [57] – Reduces paracellular cation permeability
in MDCK-I [49]
– Downregulation: Crohn's disease [94]
– Duodenum, jejunum, ileum, colon [58]
– Distal nephron, late segments of thin descending
limbs of long-looped nephrons [116]
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9 – Inner ear [57] – May play role in maturational changes
of paracellular permeability [59]
– Neonatal kidney [59]
10 – Mouse prostate [99] – Preferentially paracellular permeation of
anions (10A) or cations (10B) in MDCK-II
and LLC [13]
– 2 splice variants: 10A (kidney only) without negatively
charged aa in ECL1, 10B with negative aa in ECL1 [13]
– Inner ear [57]
– Most segments of nephron [13]
11 – Schwann' cells, Sertoli cells [14,78] – Saltatory conduction [14] – KO: nerve conduction reduced, male sterility, hind
limb weakness (no TJ in myelin/between Sertoli cells)
[14]; deafness [57]
– Mouse coroid plexus epithelium TJ [102] – Endocochlear potential [57]
– Reduces paracellular cation permeability
in MDCK-II [53]
12 – Inner ear [57], brain endothelial cells [42] – No PDZ-binding motif at C-terminus b [7]
– Duodenum, jejunum, ileum, colon [58]
13 – Duodenum, jejunum, ileum, colon [58] – May play role in the maturational
changes in paracellular permeability [59]
– Neonatal kidney [59]
14 – Inner ear [57] – Reduces paracellular cation permeability
in MDCK-II [43]
– Nonsyndromic deafness, cochlear hair cell degeneration
(mutation, e.g., human V85D in TM2) [43,120]
– Palmitoylated at conserved Cys proximal to membrane
following TMD2 and 4 [40]; KO: deafness [43]
– Sensory epithelium of organ of Corti [120]
15 – Kidney endothelial cells [80] – Increases paracellular Na+ permeability
in LLC [52]
– ECL1: acidic→basic aa exchange reverses
preference for Na+ to Cl− [66]
– Duodenum, jejunum, ileum, colon [58]
16 – Thick ascending limb of Henle's loop [70] – Increases paracellular cation
permeability (K+NNa+NMg++) in LLC
[10]; Mg++/Ca++ resorption [70]
– Familial hypomagnesaemia, hypercalciuria, nephrocalcinosis
[70] by mutations: ECL1 (H141N, R149L, L151F/W),
ECL2 (A209T, R216T, S235P) [67], C-terminus [121]
– 73 cytosolic/N-terminal aa
(other claudins have ∼7 aa) [7]
– Distal nephron of man [70], rat [67] – ECL1: excess of acidic aa, replacement
reduces Na+ permeability increase [10]
17 – mRNA in mouse [50], human kidney [7],
human/mouse taste receptor cells [122]
18 – Mouse lung epithelial cells [60] – Downregulation in gastric ca. [123] – Downstream target gene for
T/EBP/NKX2.1 homeodomain transcription
factor; 2 splice variants in ECL1 [61]
– Inner ear [57] – Extension in ECL2 [7]
– Stomach, lung [61]
19 – Kidney, retina [102], – Reduces paracellular cation permeability
in MDCK-II, increases TER [48]
– Familial hypomagnesaemia with hypercalciuria and
nephrocalcinosis, visual impairments; hypomagnesaemia
mutations in TMD1, 2 and ECL1 (Q57E) [123]
– KO: nerve conduction affected [79]
– Myelinated peripheral neurons, Schwann' cells [79] – Selective paracellular
cation barrier at TJ [68]
– Involved in electrophysiological
‘sealing’ [79]
20 – mRNA: human skin [62], rat duodenum [64] – mRNA: chondrosarcoma, brain/liver ca. [7]
21 – Human DNA sequence [65]
22 – mRNA: human trachea [65], rat duodenum [64] – mRNA: human breast ca., astrocytoma [7]
23 – mRNA: colon, stomach, placenta [65], human skin
[62], rat duodenum [64], mouse taste receptor cells [122]
– Downregulation: intestinal-type gastric ca. [124] – 111 cytosolic/C-terminal aa
(other claudins have ∼25 aa) [7]
24 – Human DNA sequence [65]
aa, amino acid; BBB, blood-brain barrier; ca., carcinoma; CPE, Clostridium perfringens enterotoxin; ECL, extracellular loop; EphA2, receptor Tyr kinase; KO, knock out mice; LLC: LLC-PK1, renal epithelial cells of
porcine proximal tubule (claudin-1, (-2), -3, -4, -7 [51]); MAPK, mitogen-activated protein kinase; MDCK, Madine–Darby canine kidney cells (I: claudin-1, -4, -7; II: -1, -2, -4, -7 [125]); PKA, cAMP depending protein
kinase A; PKC, protein kinase C; TJ, tight junctions; TER, trans endothelial/epithelial electrical resistance; TM, transmembrane domain; WNK4, a Thr/Ser kinase.
a The identity of claudin-1 is questionable (anti-claudin-1 antibodies may cross-react with claudin-3 [81] and simulate claudin-1 in the BBB).
b Most C-termini of claudins, except claudin-12 [7], reveal binding motif for PDZ domains [23, 24].
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634 G. Krause et al. / Biochimica et Biophysica Acta 1778 (2008) 631–645complete tightening of the paracellular cleft for solutes, e.g. in the
bladder, to forming paracellular pores for specific cations (and
anions), e.g. specific segments of renal tubules. Thus, TJ provide
one possibility to form tissue barriers and pores, and, hence, to
enable vital functions in all epithelial organs and organs
containing TJ-bearing endothelia, e.g., stomach, intestine, liver,
gallbladder, prostate, testis, ovary, placenta, brain, retina, inner ear
or lung (Table 1). In transmission electron microscopy, TJ appear
as fusion of the plasma membranes of opposing cells. Freeze-
fracture electronmicroscopy displays intramembranous networks
of strands and complementary grooves [1], i.e. grooves are
negative images of strands [2]. TJ strands consist of transmem-
brane proteins, such as occludin [3], tricellulin [4] and different
claudins [5]. The claudins are expressed in a tissue specific
combination resulting in tissue specific barrier characteristics.
Mammals express ∼24 claudins [6].
2. Topology and posttranslational modification of claudins
Fig. 1 summarises structural and possible interaction features
and properties of the claudin protein family. Claudins share the
tetraspan transmembrane topology with occludin, tricellulin and
connexins that form gap junctions, without considerable
sequence homology. Very great sequence homology is found
between claudins 1–10, 14, 15, 17 and 19. Combined with
functional findings, we therefore define this group as classic
claudins, as concluded from the phylogenetic tree in Fig. 2. All
other claudins are named non-classic claudins.
Intracellularly, mammalian claudins exhibit ∼7 N-terminal
amino acids, ∼12 loop amino acids, and 25–55 C-terminal
amino acids. Exceptions are claudin-12 (loop 25, human),Fig. 1. Schematic view of tight junction strands (lower part) and their major componen
of the claudin molecule, as listed in Table 1. ECL, extracellular loop; θ, negativelyclaudin-16 (N-terminal 73, human) and claudin-23 (C-terminal
111, human) [7]. The extracellular loop (ECL) 1 consists of
∼50 amino acids with two conserved cysteines involved in
the barrier function [8]. Negative [9–11] and positive [12,13]
charges in ECL1 contribute to pore formation. The ECL2
usually has ∼25 amino acids, but fewer in claudin-11 [14] and
more in claudin-18 [57]. The ECL2 has been less investigated.
It may associate with itself [15] and possess a holding function,
narrowing the paracellular cleft [16].
Transfection of TJ-free fibroblasts has demonstrated that, in
contrast to most of the other TJ proteins, claudins reconstitute
membranous strands similar to those found in epithelial cells
[17]. Occludin has also some potential to form strands.
However, the occludin strands are shorter and less complex
than those of claudins [18]. This indicates that claudins are
major constituents of TJ and that they can potentially poly-
merise. However, only in vitro data are available and only
oligomers have been identified so far, i.e. dimers up to hexamers
for claudin-5 [15,19] and for claudin-4 [20]. In non-denaturing
gel electrophoresis, hexamers seem to be the preferred oligomer
for claudin-4 and -5 [19,20] whereas claudin-1 and -3 exhibit
smaller oligomers [19].
The scaffolding proteins zonula occludens (ZO)-1 and -2
are essential for the spatial organisation of claudin-based mem-
branous strands in epithelial cells [21], but not for basic strand
formation in claudin-transfected unpolar cells [22]. At the
C-terminal positions -3, -2, -1, 0, most claudins reveal a PDZ-
binding motif, such as –K/R/H–X–Y–V. For instance, ZO-1-
PDZ1 preferentially associates with the C-terminal patterns –
K/R(T/S)–T/S–Y/W–V(L/I) [23]. Accordingly, PDZ1 of
ZO-1, ZO-2 and ZO-3 binds to claudins 1–8 [24], the multits, the claudins (top). The upper part shows possible properties on different parts
charged residue; for further explanations see Table 1.
Fig. 2. Phylogenetic tree for the full-length sequences of claudins. Classic claudins 1–10, 14, 15, 17, and 19 with high common sequence similarity are clustered in red,
non-classic claudins 11–13, 16, 18, and 20–24 are shown in black. For known mammalian, claudins in the mouse-sequences were taken as representative. Claudin-20,
-21, and -24 are only known in human (h). For each sequence, the full Swissprot accession number is stated in Fig. 4. Claudin-21 and -24 were translated (tr) from the
sequences located within human genomic contig NT_022792.13 and contig NT_033899.3, respectively [65]. The database entry XM_210581 is also called claudin-
21). This is likely a different splice variant, because most of the first extracellular loop and later sequences are identical to claudin-21_tr. Sequences were aligned by the
GCG program package (GCG Wisconsin package, Accelrys Inc., San Diego, CA). The phylogenetical distances (indicated by line length and branching) were
calculated with the program Jalview [39] and depicted with the program figtree (http://evolve.zoo.ox.ac.uk/software.html?id=figtree).
635G. Krause et al. / Biochimica et Biophysica Acta 1778 (2008) 631–645PDZ domain protein 1 (MUPP1) binds to claudin-1 [25] and
claudin-8 [26], and the Pals1-associated TJ protein PATJ binds
to claudin-1 [27]. Among the classic claudins, the –Y–V motif
in the C-terminal positions -1 and 0 exhibits 100% conserva-
tion, in contrast to a greater variety in non-classic claudins (H/
S/Y/D/E/R–V/L). This is consistent with the fact that C-
terminal peptides of claudin-2, -8, -10, -14, -17, and -20 (all
containing the C-terminus -Y-V), have binding values for the
PDZ1 of ZO-1 between 2 and 61 μM [23]. Although claudin-
16 (non-classic) contains C-terminal –R–V, it also associates
with ZO-1 [28], since it has been observed that the residues at
position -3 (T) can compensate for the binding ability [23,29].
Claudins and their tightness and pore functions are highly
dynamic, as indicated by the short half life of, e.g., claudin-4
with about 4 h [30]. In comparison, the turnover of many other
transmembrane proteins is much longer [31]. Manifold phos-
phorylations (Table 1, last column) also point to short-term
regulation of claudins. Phosphorylation can be catalyzed by
mitogen-activated protein kinase (Thr203, rat) [32] and protein
kinase C [33] in claudin-1, or by protein kinase A in claudin-3
(Thr192, human) [34] and claudin-5 (Thr207, rat) [35].
Claudin-5 phosphorylation by protein kinases Cα and ζ results
in its disappearance from the cell membrane; activation ofprotein kinase Cα increased paraendothelial permeability [36].
Claudin-1 to -4 are phosphorylated via threonine/serine kinase
WNK4 [37]. The receptor tyrosine kinase EphA2 phosphor-
ylates the PDZ-binding C-terminus of claudin-4 (Tyr208,
human), resulting in its dislocation from cell–cell contacts,
due to reduced ZO-1 association [38]. Phosphorylation of
claudin-3 may decrease the TJ strength in ovarian cancer cells
[34] and of claudin-5 in endothelial cells [35].
S-acylation has been reported in claudin-14. In epithelial
cells and fibroblasts, palmitoylation has been identified at
conserved cysteines proximal to the membrane, following the
transmembrane domains 2 and 4. The palmitoylation is required
for efficient localisation/trafficking into TJ, but not for stability
or strand assembly [40].
3. Functional properties of claudins
Table 1 gives an overview of the organ and tissue distri-
bution, functions and pathologies of individual claudins. A
general property of claudins in the TJ is the paracellular sealing
function, which is tissue-, size- and charge-selective. Knock out
mice have proven that claudin-1, -5, -11, and -14 tighten skin
[41], blood-brain barrier [42], myelin sheaths and Sertoli cell
636 G. Krause et al. / Biochimica et Biophysica Acta 1778 (2008) 631–645layers [14], and epithelium in the inner ear [43], respectively.
Claudin-3 could be relevant for tightening as a mutation
mimicking the phosphorylated state decreases the TJ strength
in an ovarian cancer cell line [34]. Claudin-4 overexpression
in ovarian cancer epithelium is positively correlated with the
paracellular resistance, which is decreased by Clostridium
perfringens enterotoxin, a ligand of this claudin [44]. In a
bladder tumour cell line, inhibition of methyl transferases
increases claudin-4 membrane expression and the resistance,
which can be prevented by claudin-4 siRNA [45], also
supporting a sealing function. Claudin-5 transfected in Caco-2
cells contributed to the barrier function [46].
After claudin-8 transfection in MDCK-II cells, the para-
cellular barrier was intensified to alkali metal and divalent
cations, to protons, ammonium and bicarbonate [47]. Trans-
fected claudin-19 increased transepithelial resistance and
decreased cation permeability [48]. Taken together, a tightness
function can be demonstrated for claudin-1, -5, -11, and -14. For
claudin-3, -4, -8, and -19, a tightening potential is indicated. The
distinct tightness properties of a given tissue and a given
claudin, however, seem to be largely dependent on the com-
bination of the claudins that are expressed and on the manner in
which they copolymerise [6,49,88].
Paracellular cation pores are formed by claudin-2 for
monovalent cations [9], by claudin-7 for Na+ [51], by
claudin-10B preferentially for cations [13], by claudin-15 for
Na+ [52], and by claudin-16 for mono- and divalent cations
[10]. These claudins, except claudin-10, have been shown to
increase paracellular cation permeability in TJ-containing
MDCK or LLC-PK1 cells. In contrast, sealing claudins, such
as claudin-4 [53], -5 [8], -8 [49], -11 [53], -14 [43], and -19 [48],
selectively decrease the paracellular cation permeability
through TJ. Claudins 2, 7, 10, 15, and 16 can therefore be
identified as pore forming claudins. In MDCK-II, the activation
energy for paracellular proton permeation was similar to that in
bulk aqueous solution. This suggests a Grotthuss mechanism
implying that the pores are sufficiently wide to accommodate
water molecules in a freely mobile state [47].
The evidence for paracellular anion pores is less clear than
that for cation pores. Claudin-10A may preferentially constitute
pores for anions [13]. The knock down of claudin-7 in LLC-
PK1 cells, renal epithelial cells of porcine proximal tubule
expressing claudin-1, (-2), -3, -4, and -7 [51], depressed Cl−
permeation [54]. In contrast, others report that the over-
expression of the same claudin decreases the Cl− permeability
[12,51]. Nevertheless, these findings are only possible if a
paracellular Cl− pore exists. If negatively charged amino acids
in the ECL1 of claudin-7 are replaced by positive ones, the Cl−
permeability increases [12]. This is a further hint that certain
claudins might generate or support Cl− pores.
Apart from the paracellular transfer of ions over the TJ barrier,
the flux of uncharged molecules may take place at TJ. Those
molecules seem to take another route, through TJ-strand-brakes,
opened during the highly dynamic rearrangement of TJ [55].
No function has been identified so far for claudins 6, 9, 12,
13, 17, 18, and 20–24. Claudin-6 [56], -9 [57], and -13 [58] are
expressed in different types of cells and may play a role in thematuration of the epidermis or the paracellular permeability
[59]. For claudin-12 [42,57,58] and -18 [57,60,61], the protein
has been detected in epithelia and endothelia of gastrointestine,
inner ear, or brain endothelial cells. For claudin-17 [7,50], -20
[7,62,63], -22 [7,63,64], and -23 [62,64,65], only the mRNA
has been identified, e.g., in kidney, colon, stomach or placenta
of different species, such as human, mouse or opossum. The
existence of claudin-21 and -24 has been solely derived from
the analysis of the human genome [62].
4. Extracellular loops of claudins and their cell–cell contact
function
To understand the function of claudins in TJ one has to
consider their extracellular loops. TJ are most probably
constituted via interactions of the ECLs which are exposed to
the opposing membrane within the cell–cell contact. This is
supported by mutations in the ECL1 [8,10,66–68] and ECL2
[16,67], both affecting cell–cell contact functions. Comparison
of the different claudin properties listed in Table 1 shows that
the ECLs mainly determine paracellular solute tightness and
paracellular ion permeability.
4.1. ECL1, sealing and pore forming function
Several studies on paracellular tightness have demonstrated that
claudinswith tightening properties, such as claudin-4 [53], -5 [8], -
8 [49], -11 [53], -14 [43], and -19 [48], reduce paracellular cation
permeability when transfected into TJ-containing cells, such as
MDCK-II. On the other hand, pore forming claudin-2 [9], -15 [52],
or -16 [10] may facilitate paracellular cation permeability when
transfected in pore-containing epithelia. In addition, replacement
of basic by acidic residues in claudin-4 ECL1 increases cation
permeability. Exchange of acidic to basic residues in claudin-15
ECL1 reversed paracellular charge selectivity from a preference
for cations to anions [66]. The claudin-16 ECL1 shows an excess
of negatively charged amino acids. Substitution ofmost of themby
non-charged ones removed their Na+ facilitating permeability
while all substitutions of positively charged amino acids did not
[10]. This underlines the significance of negative residues in ECL1
for the cation pore formation.
Mutations in the ECL1 (H71D, L75P, R79L, L81F/W) or
ECL2 (A139T, R146T, S165P) of claudin-16 [67,69] result in
familial hypomagnesaemia, hypercalciuria and nephrocalcino-
sis [70]. A mutation in claudin-19 ECL1 (Q57E) causes hypo-
magnesaemia [68]. These mutations lead to a better molecular
understanding of the malfunctions. For claudin-7, replacement
of negatively charged amino acids against positively charged
ones in the ECL1 but not in the ECL2, increased the Cl−
permeability without changing the targeting to cell junctions
[12]. This supports the assumption that the ECL1 and not the
ECL2, determines whether a pore is formed.
4.2. ECL2 function
The ECL2 seems to be of general relevance, at least in the
group of classic claudins. For the classic claudin-5, a holding
637G. Krause et al. / Biochimica et Biophysica Acta 1778 (2008) 631–645and narrowing function has been proposed for this ECL [16].
However, for a proper TJ function, cooperation between both
loops seems to be necessary. It was shown that a specific motif
in ECL1 and ECL2 and their proper arrangement to each other
are involved in claudin-3/-4 interaction [71].
Other claudin segments may also contribute to the TJ
function, as indicated after phosphorylation of the intracellular
C-terminal tail [34,35] (Section 2). Similarly, intramembranous
parts might play a role, as suggested by mutations in
transmembrane domains of claudin-14 [72], -16 [69] and -19
[68]. However, the mutations exhibit intracellular accumulation
which is most probably due to misfolding and does not prove
their involvement in barrier function.
5. Claudin–claudin interactions and the formation of tight
junction strands
Claudins may self-associate in two orthogonal orientations,
as shown for claudin-5 [15,16] as is known for the adherens
junction proteins cadherins [73]. We therefore propose adopting
the nomenclature of cadherin–cadherin interaction to that
of claudins. Possible interactions for claudins via their ECLs
are outlined in Fig. 3, lower part. Thus, claudin-5 moleculesFig. 3. Tabulated interaction possibilities between claudins as, for example, reported f
interactions based on a nomenclature described for cadherins [73], a group of adher
(A) homophilic cis- and trans-interactions, (B) heterophilic trans-interaction and ho
interaction as well as (D) heterophilic cis- and trans-interactions (modified accordincan interact along the plasma membrane of the same cell
(cis-interaction), as demonstrated by fluorescence resonance
energy transfer [15,16]. In addition, the ECLs may associate
between the plasma membranes of opposing cells (trans-
interaction). As far as has been analysed, the cis-interaction of
claudin-5 cannot be affected by amino acid exchange in the
ECL2. This indicates that other claudin parts are primarily
involved. In contrast, the trans-interaction, exclusively occur-
ring in the TJ, can be influenced by amino acid substitutions in
the binding core of this ECL2 [16]. This supports a strong
contribution of the ECL2 to the trans-interaction of claudin-5
(holding and narrowing function).
Moreover, homo- and heterophilic associations have been
observed [74]. Molecules of one claudin family member may
bind to each other (homophilic interaction) or to molecules of
other family members (heterophilic interaction). However,
little is known about how claudins interact at the molecular
level. Table 2, upper part, summarises homophilic trans-
interactions (also termed homotypic interactions [71]) for
claudins 1, 2 [17,74], 3 [19,74], 5 [15,19,75], 6 [56,76,77], 9
[77], 11 [78], 14 [40,72,77] and 19 [79]. These claudins are
able to form TJ when transfected into TJ-free cells (schematic
view see Fig. 3A).or claudin-1 and -3 [74]. Lower part: homophilic and heterophilic cis- and trans-
ens junction proteins. Upper part: schematic tight junction strands consisting of
mophilic cis-interaction (C) homophilic trans-interaction and heterophilic cis-
g to [74]).
Table 2
Tight junction-like strand formation of tight junction free-cells transfected with exogenous claudins — Indications for trans-interactions between claudin's
extracellular loops presented from the cell surface of opposing cells
Claudin trans-
interaction
Cell type Condition Freeze-fracture electron microscopy of tight junctions References
Strand morphology Association Comment
1 Homophilic L Transfected Continuous strands P-face [17,82]
Continuous grooves E-face Complementary
1 Homophilic NIH/3T3 Transfected Linear strands with connections [19]
2 Homophilic L Transfected Discontinuous strands, particles in grooves E-face [17,74]
Ridges with particles P-face
3 Homophilic L Transfected Continuous strands P-face [108]
Continuous grooves E-face Complementary
3 Homophilic NIH/3T3 Transfected Non-linear strands, few connections [19]
5 Homophilic L Transfected Discontinuous strands, particles in grooves E-face [75]
Particle-free ridges P-face
5 Homophilic NIH/3T3 Transfected Discontinuous strands [19]
5 Homophilic HEK Transfected Discontinuous strands, branched E-face cis-interaction
simultaneously shown
[16]
6 Homophilic L Transfected Discontinuous strands, particles in grooves E-face [76]
Ridges with particles P-face
6 Homophilic HEK Transfected [56]
6 Homophilic COS-7 Transfected Meandering, anastomosing strands [77]
9 Homophilic COS-7 Transfected Meandering, anastomosing strands [77]
11 Homophilic L Transfected Discontinuous strands (few branched,
often parallel, varying particle distance)
P-face [78]
14 Homophilic L Transfected Continuous, short strands [72]
Continuous, short grooves Complementary
14 Homophilic COS-7 Transfected Parallel strands E-face [77]
19 Homophilic L Transfected Continuous strands [79]
1/2 L Cotransfected Fragmented continuous strands P-face Heterophilic
cis-interaction assumed
[74]
Scattered particles in grooves E-face
No heterophilic L Coculture a No strands [74]
1/3 + L Cotransfected Continuous strands P-face [74]
Continuous grooves E-face Complementary
Heterophilic L Coculture a Continuous strands P-face [74]
Continuous grooves E-face Complementary
1/3 + NIH/3T3 Cotransfected Continuous strands (as polarised epithelia) P-face Heterophilic cis- and/or
trans-interaction
[19]
2/3 + L Cotransfected Fragmented continuous strands P-face Heterophilic cis-interaction [74]
Scattered particles in grooves E-face
Heterophilic L Coculture a Continuous claudin-3 strands P-face [74]
Discontinuous claudin-2 strands E-face
3/4 HeLa Cotransfected Heterophilic cis-interaction [71]
3/5 + NIH/3T3 Cotransfected Continuous strands (as polarised epithelia) P-face Heterophilic cis- and/or
trans-interaction
[19]
Heterophilic HeLa Coculture a [71]
4/1, 4/3, 4/5 No heterophilic HeLa Coculture a [71]
L, mouse L-fibroblasts; NIH/3T3, mouse fibroblasts; HEK, human embryonic kidney cell line 293; COS-7, African green monkey kidney cells (fibroblast-like); HeLa,
human cervix epithelial carcinoma cells; P- or E-face association, tight junction strands found in the protoplasmic or exoplasmic face of the freeze-fracture replica.
a Coculture of monotransfected cells.
638 G. Krause et al. / Biochimica et Biophysica Acta 1778 (2008) 631–645Heterophilic trans-interaction (or heterotypic interaction
[71]) between different claudins (Fig. 3B) has been observed
for claudins 1↔3, 2↔3 [74] and 3↔5 [19,71]. The heterophilic
interactions imply that compatible structural features of the
ECLs are conserved, at least, throughout these claudins. The
heterophilic interactions are sensitive to small changes in the
ECLs [71]. However, how claudins interact at the molecular and
structural level to seal the paracellular cleft and to form pores, is
an unsolved question. On the other hand, it has not been
possible to demonstrate a heterophilic trans-interaction for
claudins 1↔2 [74], 1↔4, 3↔4, and 4↔5 [71] (Table 2, lowerpart). This demonstrates that only certain claudins are able to
interact with each other.
Homophilic cis-interaction (or homomeric interaction [71])
is described for claudin 5↔5 using a FRET assay [15,16].
Heterophilic cis-interactions (or heteromeric interactions [71])
are found for claudins 2↔3 [74], 3↔4 [71] and assumed for 1↔2
[74], respectively. Most epithelia and endothelia express a
mixture of different claudins which is specific for the function of
a tissue or parts thereof (e.g., variation along the nephron [80]).
Consequently, heteropolymers are most likely and these can be
formed in different ways (possibilities see Fig. 3B–D).
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freeze-fracture electron microscopy [1]. The latter shows
claudin strands in different layers of the TJ membrane
[81,75]. However, molecular considerations and discrimination
between different claudins are difficult in TJ-expressing cells or
tissues. To overcome this difficulty, TJ-free fibroblasts [17,74–
76,78,79,82], COS-7 [77], NIH/3T3 [19], and HEK-293 [16,56]
were introduced to analyse homophilic and heterophilic trans-
interactions in TJ after the transfection of claudins. In addition,
trans-interaction is investigated as claudin enrichment in cell–
cell contacts (TJ) [16]. cis-interactions can be studied in living
cells by fluorescence resonance energy transfer after exogenous
expression of claudins C-terminally fused with fluorescent
proteins [15,16]. Non-denaturing gel electrophoresis may give
hints of the size of claudin oligomers [19,20] and coimmuno-
precipitation provides hints of heterophilic interactions [19].
Analysis of recombinant claudin segments with size-exclusion
chromatography, light scattering or mass spectrometry [15], as
well as the effect of peptides [83], may further characterise
claudin interactions.Fig. 4. Alignment of sequences of the extracellular loops (ECL) 1 and 2 from claudin
Diego, CA). The claudins are grouped by sequence similarity in classic and non-class
taken as representative. Claudin-20, -21, and -24 are only know in human (h). Num
accession number is stated. From claudin-10 and -18, two isoforms with differenc
exchange in the ECL2. The consensus sequences for the classic and non-classic as w
small letters (N70% identity) sequence identity, respectively. Green: hydrophobic, bl
tyrosines, black: prolines. Classic claudins showed in ECL1 predictions of β-stra
predictions were applied by multiple methods using program jpred [90]. Arrows, β-6. Alignment of the extracellular loops of claudins
The alignment and phylogenetic tree analysis of whole-
length sequences of claudins led to differentiation of two groups;
the classic claudins have very high common sequence similarity,
but non-classic claudins possess low similarity (Fig. 2). This is
even sustained and affirmed for the extracellular loop sequences
of ECL1 and ECL2, by inspecting their alignment separately
(Fig. 4). Classic claudins exhibit a much stronger consensus
sequence than non-classic claudins.
As shown in Fig. 4, left alignment, the ECL1 of the complete
claudin protein family consists of 50–56 amino acids, wherein
the non-classic group exhibits a much higher sequence variety
than the classic group, which has a higher number of consensus
amino acids. Two cysteines (e.g., positions 54 and 64, human
claudin-1) are conserved in all claudins and are reported to be
essential for tightness function [8]. Non-conserved negatively
charged residues in the ECL1 of claudin-2 [9], -15 [11], and -16
[10] are thought to be responsible for cation pore formation at
TJ. In general, it seems that in the ECL1 an excess of eithers with the GCG program package (GCG Wisconsin package, Accelrys Inc., San
ic ones (see Fig. 2). For each mammalian claudin, the mouse-sequences (m) were
bers of amino acids are taken from cld1_m. For each sequence the Swissprot
es in ECL1 are known. The two claudin-23 sequences possess an amino acid
ell as for all claudins are given in capital letters (N90% sequence identity) and
ue: basic, magenta: acidic, violet: hydrophilic residues, yellow: cysteines, cyan:
nds and in ECL2 a prediction of two α-helices. Secondary structure element
strands; tubes, α-helices; yellow, strong prediction; beige, weak prediction.
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pores with preference for the passage of cations or anions,
respectively. This can be exemplified by the two splice variants
of claudin-10, which are moderately charge selective. Claudin-
10A has an excess of positive charges in this ECL and that of
claudin-10B an excess of negative charges. Thus, claudin-10A
is reported to convert the selectivity more to Cl− than to Na+,
and claudin-10B more to Na+ than to Cl− [13].
The ECL2 of classic claudins (Fig. 4, right alignment)
consists of ∼25 amino acids. In non-classic claudins, the ECL2
varies in length from 17 (claudin-11) [14] to 39 (claudin-18) [7]
and, to a larger extent, in the amino acid sequences. A defined
sequence length of ECL2 for all claudins is difficult to state,
since the predictions of the borderlines for transmembrane (TM)
regions vary for different claudins, even among the classic ones.
This can be exemplified for claudin-5, where more hydrophobic
residues at the N-terminal side of the ECL2 lead to extension of
the predicted TM3 region and a decreased ECL2 length. This
prediction is shown in the annotation to the claudins in theFig. 5. Suggested molecular interactions between extracellular domains of homophilic
extracellular loop (ECL) 1 as well as narrowing and holding function of the ECL2.
repulsion that allows paracellular anion or cation permeation is supported by favou
residues at the ECL, lining the respective pore. (B) The tightness between claudins is
(likely by charge attraction), preventing the paracellular ion permeation. Blue bar, bl
general representation of claudin polymer consisting of oligomers (columns) assume
portion with a helix–turn–helix structure of the protein 2BDV identified at the Pro
sequence of claudin-5. Two α-helical structures (orange, cyan) linked by a turn ar
monomer structure is highly consistent to all mutants disturbing the fold (intracellula
are stabilising the turn conformation by H-bonds or hydrophobic interaction. (D)
homophilic trans-interaction of two ECL2 that is partly consistent with mutant pheno
in inserted table, disjunction phenotype). Aromatic amino acids are likely forming an
lines indicate the border between TMH and ECL. Amino acid positions, mouse clauSwissprot database and by other TM prediction methods, such
as SPLIT4 [84], HMMTOP2 [85], and TMHMM2 [86]. The
different TM length may indicate either different TM tilt within
the membrane or different elongation of potential transmem-
brane helices into the extracellular side for some claudins. The
occurring consensus “dFy.Pl” (Fig. 4, right upper part) in the
middle of the ECL2 amino acid sequence is part of a predicted
helix with a following turn structure at the classic group [16].
7. Interaction models of claudin extracellular loops
Due to the lack of X-ray or NMR structural data for
interacting claudins, no detailed information down to atom
level is available. Only global schemes have been proposed
[87,88]. These point to general participation of charged
residues aligned in the ion pore, as demonstrated by mutations
[12,13,66,89]. To gain insight in potential structures of the
ECLs of claudins, we performed secondary structure predic-
tions using the program jpred [90]. They indicate mainly β-claudins in tight junctions, explaining pore formation and tightening by the first
Schemes for ECL1: (A) The charge depending pore formation likely by charge
red spatial placement of an overplus of either positively or negatively charged
likely produced by a differently distribution and facing of charged amino acids
ocked ion permeability; + in red circle, cation; − in blue circle, anion; dark grey,
d. Comparative molecular model for ECL2 adapted from [16]: (C) A sequence
tein Data Bank (http://www.rcsb.org/pdb/) is highly homologous to the ECL2
e likely extracellular extensions of transmembrane helices TMH3 and 4. This
r phenotype, red in the inserted table) since the side chains of wild type residues
Based on the monomer, a tentative anti-parallel dimer model is suggested for
types that are localised at the membrane and disturbed the trans-interaction (blue
aromatic core, which hold onto each other between opposing cells [16]. Dashed
din-5.
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classic claudins (Fig. 4).
For the ECL1, the two following schemes can be sum-
marised: (i) The pore forming property supporting the para-
cellular ion permeation is favoured, probably because of charge
repulsion by spatial placement of equally charged residues in the
ECL1, since pore formation depends on the spatial location,
distribution and facing of equally charged residues (Fig. 5A).
(ii) The tightness property is supported by a different distribution
and facing of charged amino acids, preventing pore formation
and paracellular cation permeation via the ECL1, probably due
to charge attraction (Fig. 5B).
In the case of ECL2, more detailed information is available
[16]. Based on mutagenesis and morphological data of claudin-
5, molecular modelling led to a homology model of a monomer,
which explains folding/transport defects caused by the mutants
(Fig. 5C). The experimental data suggest that the ECL2 is
involved in TJ strand formation via trans- but not cis-interaction.
Based on the monomer model, a tentative anti-parallel homo-
dimer model has been proposed (Fig. 5D). This first dimermodel
is consistent with the finding that three aromatic amino acids
(F147, Y148, Y158) are involved in the trans-interaction. The
results still do not explain how two further residues (Q156,
E159) are also involved in the trans-interaction. Possibly, the QFig. 6. Scheme for the formation of tight junction strands by a single claudin and the
claudin-1 triggers the formation of polymeric strands and continuous cis-interaction
cannot slide out of the protoplasmic(P)-face due to the continuity and are observed o
claudin-5 monomers form oligomers, e.g. hexamers in one membrane. trans-interacti
fracturing, the claudin-5 oligomer slides out of the P-face and is seen on the exoplasmic
of observation in the freeze-fracture replica; red dotted line, freeze-fracture plane. Rectand E interact with other parts of themolecule (e.g. ECL1). Since
nearly all the residues which were of relevance for the interaction
are conserved in the classic claudin group, the proposed
mechanism might be of general importance for classic claudins.
8. Schemes for strand formation
As shown in Table 2, two types of strand morphology have
been described after transfection of claudins in TJ-free cells.
Continuous strands are observed for claudin-1 [17,19,74], -3
[74], -14 [40,72] and -19 [79]. This means that these claudins
form continuous strands associated with the protoplasmic face
(P-face) of the membrane when visualised by freeze-fracture
electron microscopy [17]. On the other hand, rows of particles
of up to about 10 nm in size [11,19,20], separated by spaces of
mainly similar length, are obtained with claudin-2 [11,74], -5
[16,19,75], -6 [76] and -11 [78] (discontinuous strands). The
particles in discontinuous strands are associated with the
exoplasmic face (E-face) of the membrane after freeze-
fracturing [75]. For claudin-2 [17,74], -6 [76] and -11 [78],
intramembranous particles were seen on the P-face also.
This diversity might be due to different properties in cis-
oligomerisation. In vitro evidence suggests that claudins
possess a general potential for oligomerisation. In semi-nativeir appearance after freeze-fracture electron microscopy. (A) trans-interaction of
supports this polymerisation. (B) During freeze-fracturing, the claudin-1 strands
n the P-face of the membrane as continuous strands. (C) Due to cis-interaction,
on triggers the formation of polymeric discontinuous strands. (D) During freeze-
(E)-face of themembrane as a line of particles. Black arrows indicate the direction
angle, claudin monomer. For explanation of cis- and trans-interactions see Fig. 3.
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detected as a larger oligomer than claudin-1 [19]. Claudin-5
preferentially forms hexamers [19], but does not polymerise in
one cell [16]. Only trans-interaction between oligomers at TJ
triggers the formation of polymeric strands between the cells
[16]. As polarised cells express different claudins, one has to
assume that heterophilic claudin–claudin interactions also take
place. Strand formation is, at least, caused by interactions of
ECLs. For claudin-5, this is documented by amino acid
replacement studies in the ECL2, which led to abolishment of
strands or marked alterations in strand morphology [16].
The 10 nm size of the discontinuous particles [17,19,20]
matches the size of connexin hexamers determined by electron
microscopy, size-exclusion chromatography or density gradient
centrifugation [91–93]. Since claudin molecules are roughly the
same size as those of connexins and also consist of 4
transmembrane helices, it is conceivable that they may also
form hexamers in vivo even though the configuration would be
different. This is supported by biochemical data indicating that
claudins such as claudin-4 and -5 can occur as oligomers of
different sizes, but preferentially as hexamers [19,20].
The oligomerisation data mentioned above result in schemes
for strand formation, which were developed for classic claudins
(Fig. 6). Claudin-1 forms continuous polymers within the TJ
membrane [17,19,82], triggered by trans-interaction and
probably supported by continuous cis-interaction (Fig. 6A).
Maybe due to the continuity, the polymers are not able to slide
out of the P-face and are therefore detected as continuous
strands on the P-face in freeze-fracture replica (Fig. 6B). On the
contrary, claudin-5 generates oligomers (e.g. hexamers) but not
polymers in the TJ membrane. These particles (Fig. 6C) are able
to slide out of the P-face and, therefore, appear on the E-face in
freeze-fracture replica [75,16,19] (Fig. 6D). This could be due
to strong trans-interaction and the lack of continuity in the
membrane. Claudin specific anchorage to the cytoskeleton
cannot explain the P-/E-face association, since it is also
observed when the anchorage is blocked [16]. In contrast to
claudin-transfected TJ-free cells, different claudins probably
copolymerise in vivo, resulting in continuous strands, as found
for epithelial [94] and endothelial cells [81]. Hence, the dis-
continuity of claudin-5 strands in TJ-free cells [16,19,75] could
be due to the fact that other claudins are missing and supports
the concept of heteropolymerisation in vivo.
Pathological conditions may influence strand morphology.
Discontinuous strands can be found in colon biopsies of
Crohn's disease, due to changes in expression and distribution
of claudins 2, 5 and 8 [94]. Brain degeneration may lead to a
loss of claudin-3, but not of claudin-5, at TJ in cerebral
endothelial cells [81], also changing the claudin composition of
the TJ. In conclusion, a defined claudin composition and stoi-
chiometry seems to be essential for the formation of continuous
strands.
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